
If you have recently tried to refill your estradiol patch and discovered that your pharmacy doesn't have it, you are not alone.
Women across the country are reporting difficulty finding their usual estrogen patches. The FDA has now acknowledged the problem and says it is working with manufacturers to increase the supply.
And there is a rather remarkable reason for the sudden demand.
After more than two decades of frightening women about menopausal hormone therapy, the FDA began removing some of the notorious boxed-warning language from menopausal hormone products in late 2025. In February 2026, the FDA approved labeling changes removing boxed-warning statements concerning cardiovascular disease, breast cancer, and probable dementia from several menopausal hormone therapy products.
Think about that for a moment.
For more than 20 years, an entire generation of women was taught to fear estrogen.
Many women stopped taking hormones. Many physicians stopped prescribing them. And countless women suffered unnecessarily with hot flashes, night sweats, insomnia, vaginal dryness, brain fog, mood changes, and other symptoms of estrogen loss.
Now the pendulum is swinging back.
And suddenly women are discovering something many of us in women's health have been saying for decades: Estrogen is not the enemy.
But there's another important point I want women to understand.
An estradiol patch is simply one delivery system for estrogen.
It happens to be a very convenient one. Estradiol passes through the skin and enters the circulation without first passing through the liver. For many women, transdermal estrogen is an excellent choice.
But if your patch is unavailable, that does not necessarily mean you have to go without estrogen.
There are other ways estrogen can be delivered.
Depending upon your medical history and individual needs, your clinician may be able to prescribe:
Some women also use custom-compounded hormone preparations, including creams and troches. These are different from FDA-approved preparations and require knowledgeable individualized prescribing because compounded products have not undergone the same FDA review for dosing consistency, absorption, safety, and effectiveness.
And remember: route matters.
Oral estrogen passes through the liver before reaching the systemic circulation. Transdermal estrogen—whether delivered through a patch, gel, or spray—largely bypasses that first-pass liver metabolism. This can make a meaningful difference in the risk-benefit calculation for an individual woman.
This is why menopause care should never be one-size-fits-all.
There is another category that receives far too little attention in conventional discussions about menopause: phytoestrogens.
Phytoestrogens are naturally occurring plant compounds that can interact with estrogen receptors in the human body.
And one plant researchers have been interested in for many years is Pueraria mirifica, a plant native to Thailand and traditionally used by women for generations.
Pueraria mirifica contains several estrogenically active compounds, including miroestrol and related phytoestrogens. It has attracted scientific interest precisely because of its estrogenic activity.
In one randomized clinical study of perimenopausal women, Pueraria mirifica significantly reduced menopausal symptoms over six months, with symptom improvement that was not statistically different from the comparison hormone-therapy group. This is one reason this remarkable plant deserves considerably more attention.
This is also the botanical at the heart of the Amata Life Pueraria Mirifica Plus, which contains a standardized Pueraria mirifica extract.
I want to be very clear about something:
I am not suggesting that a dietary supplement is a one-for-one replacement for your prescription estradiol patch.
If you are doing beautifully on your hormone regimen, my philosophy has always been: If it isn't broken, don't fix it.
And if you suddenly cannot obtain your patch, don't simply stop your medication or substitute something else on your own. Talk with your clinician or pharmacist about the alternatives available to you.
But I am suggesting that women deserve to know the full landscape.
For decades, menopause was treated as either something women should simply endure or something too dangerous to treat effectively.
Neither position serves women.
Menopause is not a disease.
But neither should women be expected to suffer needlessly from the physiologic consequences of declining ovarian hormones.
The extraordinary surge in demand for estrogen tells me that women are finally beginning to reclaim this conversation. And that is good news.
Whether you choose an estradiol patch, another form of prescription hormone therapy, botanical support, lifestyle approaches, or some combination of these, the important thing is to become an informed steward of your own body.
Know what estrogen does.
Know your individual risks.
Know your options.
And above all, don't let a pharmacy shelf—or another swing of the medical pendulum—convince you that you are powerless.
Your body is not a problem to be solved. It is a brilliantly designed system to be understood, supported, and wisely stewarded.
In health,
Christiane Northrup, M.D.
Medical note: Menopausal hormone therapy is not appropriate for every woman. Systemic estrogen has important contraindications and potential risks, and women with a uterus generally require adequate endometrial protection when using systemic estrogen. Dietary supplements can also have biologic effects and may not be appropriate for everyone. Decisions about changing prescription hormone therapy should be made with a qualified healthcare professional.
Please note that this blog forum does not allow responses to individual questions, which instead should be forwarded to customer service at 800-760-9090, or customerservice@amatalife.com. We’re prohibited from providing medical advice, but will do our best to help where we can.